Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosis - Dooley, K E; Mitnick, C D; Ann DeGroote, M (Clin Infect Dis, 2012)
, et al; Efficacy Subgroup, RESIST-TB.